+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour



Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour



Zhonghua Fu Chan Ke Za Zhi 40(2): 79-82



To evaluate the results of etopside, methotrexate, kengshengmycin/etopside, cisplatin (EMA/EP) chemotherapy in patients with chemorefractory gestational trophoblastic tumour. Fifteen patients with chemorefractory gestational trophoblastic tumour were treated by EMA/EP chemotherapy schedule. Twelve of the fifteen cases were choriocarcinoma, and the other three were metastatic placental site trophoblastic tumour (PSTT). International Federation of Gynecology and Obstetrics (FIGO), 2 cases stage I, 10 cases stage III, 3 cases stage IV. Eight cases had FIGO score of 7 to 12, the score of the other 7 cases was over 12. Fifteen patients received a total of 93 cycles of the study regimen. The median number of courses for each patient was 6.2. Eleven cases (73%) achieved a complete remission while 3 patients (20%) had a partial remission, 1 case (7%) showed nonresponse. The main complications for EMA/EP chemotherapy were myelosuppression and gastrointestinal symptoms. The EMA/EP regimen is an effective treatment for chemorefractory gestational trophoblastic tumour, and the chemotherapeutic results can be further improved while combined with surgery and arterial infusion chemotherapy in the selected patients. Meanwhile, EMA/EP regimen should be considered in the primary management of patients with metastatic PSTT.

(PDF emailed within 1 workday: $29.90)

Accession: 048989152

Download citation: RISBibTeXText

PMID: 15840283


Related references

Methotrexate combined chemotherapy for chemorefractory gestational trophoblastic tumour. Zhonghua Fu Chan Ke Za Zhi 34(2): 97-100, 2001

Chemotherapy of advanced metastatic nonseminomatous germ cell tumors with etopside, cisplatin, bleomycin, and cyclophosphamide. Annals of Hematology 65(SUPPL ): A59, 1992

Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia. Zhonghua Fu Chan Ke Za Zhi 42(9): 595-599, 2007

Comparison of carboplatin/etoposide/vincristine with cisplatin/etopside as combination chemotherapy for small cell lung cancer. Tokai Journal of Experimental & Clinical Medicine 20(4-6): 209-214, 1995

New chemo therapies of bronchogenic carcinomas use of cisplatin and etopside. Louvain Medical 100(4): 221-226, 1981

EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor. Journal of Reproductive Medicine 49(6): 443-446, 2004

Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. Journal of Clinical Oncology 18(4): 854-859, 2000

Tumour vascularity assessed using Doppler ultrasound predicts the risk of resistance to methotrexate chemotherapy in gestational trophoblastic tumours. British Journal of Cancer 85(Supplement 1): 26, July, 2001

Conservative Chemotherapy in Gestational Trophoblastic Disease: Experience With Etoposide, Methotrexate, and Dactinomycin Chemotherapy. International Journal of Gynecological Cancer 26(4): 790-795, 2016

Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia. European Journal of Cancer 49(4): 860-867, 2013

The role of methotrexate in the chemotherapy of gestational trophoblastic neoplasms. Advances in Experimental Medicine and Biology 176: 343-354, 1984

Single methotrexate chemotherapy for low-risk gestational trophoblastic tumor. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 25(4): 414-417, 2003

The purpose of methotrexate saturation test in chemotherapy of gestational trophoblastic disease. Journal of Catholic Medical College 44(1): 213-222, 1991

Salvage surgery for chemorefractory gestational trophoblastic disease. Journal of Clinical Oncology 12(12): 2737-2742, 1994

Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors. American Journal of Obstetrics & Gynecology 172(2 PART 1): 574-579, 1995